Clinical Trials for Akero Therapeutics

Explore 4 clinical trials worldwide

Showing 1-4 of 4 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Akero Therapeutics

Clinical Trials (4)

NCT06528314
A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
PHASE3Recruiting
1,150 participants
Started: Sep 4, 2024 · Completed: Oct 31, 2029
2 conditions1 sponsor285 locations
NCT06215716
A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis
PHASE3Recruiting
1,650 participants
Started: Dec 1, 2023 · Completed: Nov 30, 2032
2 conditions1 sponsor332 locations
NCT06161571
A Study Evaluating Efruxifermin in Subjects With Non-invasively Diagnosed Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Nonalcoholic Fatty Liver Disease (NAFLD)/Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
PHASE3Active, not recruiting
700 participants
Started: Nov 10, 2023 · Completed: Oct 31, 2026
2 conditions1 sponsor211 locations
NCT05039450
A Study of Efruxifermin in Subjects With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis (NASH) (Symmetry)
PHASE2Active, not recruiting
182 participants
Started: Jul 30, 2021 · Completed: May 31, 2025
1 condition1 sponsor49 locations